An interesting point on
“.... How do we truly define a today? ... Are making the “wrong” kinds of molecules?
Or have we entered a new era of drug modalities?
.... And just to prove chemists can continue to make the “right” kinds of molecules, here are some recent low Mw drug -
-       Tecfidera (Mw 144), approved 2013
-       Tavaborole (Mw 151), FDA approved 2014
-       Avibactam (Mw 265), FDA approved 2015
-       Benznidazole (Mw 260), FDA approved 2017
-       Migalastat (Mw 163), FDA approved 2018
 
How many novel small molecule drugs Mw<300 are yet to be discovered?”

linkedin.com/posts/trevor-bret

@marcoradi On the other hand, large molecules are chanting 'the-larger-the-merrier', from mAb to bispecific to trispecific...

Follow

@MingqingCai but the small-molecules are humble fellows and don’t brag about their merits becasuse they know that less is more...

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.